PIM1 and T-cell non-Hodgkin lymphoma: This work demonstrated that in addition to the strong synergy between runx2 and myc, runx2 seemed to collaborate independently with pim1, demonstrating that it contributed to T-cell lymphoma development in a unique manner with a dominant effect on the tumor cell lineage and phenotype (55).